文献速递免疫规划

评估日本儿童水痘普遍免疫规划的实施效果

Evaluating the effectiveness of the universal immunization program against varicella in Japanese children.
PubMed 文献 · Vaccine · 2017-08-04

本研究采用匹配病例对照设计,在日本实施水痘普遍免疫规划后不久,评估Oka/Biken疫苗的效果。病例为2015年9月至2016年9月在14家指定儿科诊所确诊的15岁以下实验室确诊水痘患者,对照为同期因其他原因就诊的患儿。结果显示,接种1剂疫苗的效果为76.7%(95%CI:58.6-86.9%;P<0.001),接种2剂为94.2%(95%CI:85.7-97.6%;P<0.001);调整混杂后分别为76.9%(95%CI:58.1-87.3%;P<0.001)和94.7%(95%CI:86.0-98.0%;P<0.001)。结论认为1剂疫苗不足以控制水痘,2剂疫苗对日本控制水痘具有重要意义。

要点

  • 接种1剂Oka/Biken疫苗对比未接种的疫苗效果为76.7%(95%CI:58.6-86.9%;P<0.001)。
  • 接种2剂Oka/Biken疫苗的疫苗效果为94.2%(95%CI:85.7-97.6%;P<0.001)。
  • 调整潜在混杂后,1剂和2剂疫苗效果分别为76.9%(95%CI:58.1-87.3%;P<0.001)和94.7%(95%CI:86.0-98.0%;P<0.001)。

核心结论

  • 1剂Oka/Biken水痘疫苗的疫苗效果不足以控制水痘,2剂Oka/Biken水痘疫苗对日本控制水痘具有重要意义。

研究设计与样本

  • 匹配病例对照研究,病例为2015年9月至2016年9月在14家指定儿科诊所确诊的15岁以下实验室确诊水痘患者,对照为同一诊所2周内因其他原因就诊的患者。
  • 对水痘疑似患者采集拭子样本,采用分子诊断方法确认水痘病例。
  • 采用匹配比值比计算疫苗效果(VE)。

主要发现

  • 225例疑似病例中183例(81.3%)检测出水痘-带状疱疹病毒DNA,其中1例因Oka疫苗株阳性被排除(182/225,80.9%)。
  • 共纳入323名对照。
  • 接种1剂Oka/Biken疫苗对比未接种的疫苗效果为76.7%(95%CI:58.6-86.9%;P<0.001)。
  • 接种2剂Oka/Biken疫苗的疫苗效果为94.2%(95%CI:85.7-97.6%;P<0.001)。
  • 调整潜在混杂后,1剂和2剂疫苗效果分别为76.9%(95%CI:58.1-87.3%;P<0.001)和94.7%(95%CI:86.0-98.0%;P<0.001)。

临床怎么用

  • 作者认为,1剂Oka/Biken水痘疫苗的疫苗效果不足以控制水痘,2剂Oka/Biken水痘疫苗对日本控制水痘具有重要意义。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Matched case control study was conducted to elucidate the effectiveness of the Oka/Biken vaccine immediately after implementation of the universal immunization program in Japan. METHODS: Cases were laboratory confirmed varicella patient under 15years of age diagnosed at 14 designated pediatric clinics between September 2015 and September 2016. Controls were selected from patients who visited the same practice for different reasons as the varicella case within 2weeks. Swab samples were collected from varicella suspected patients and molecular diagnostic assays were used to confirm varicella cases. Matched odds ratio were used to calculate vaccine effectiveness (VE). RESULTS: Varicella zoster virus DNA was detected in 183 (81.3%) of 225 suspected cases. One sample was excluded because it was positive for the Oka vaccine strain (182/225, 80.9%). Three hundred twenty-three control subjects were enrolled. The effectiveness of 1 dose of the Oka/Biken vaccine compared with no vaccine was 76.7% (95% confidence interval [CI]: 58.6-86.9%; P<0.001). The effectiveness of 2 doses of the Oka/Biken vaccine was 94.2% (95% CI: 85.7-97.6%; P<0.001). After adjusting for potential confounding effects, the adjusted VE of 1 and 2 doses of varicella vaccine were 76.9% (95% CI: 58.1-87.3%; P<0.001) and 94.7% (95% CI: 86.0-98.0%; P<0.001), respectively. CONCLUSIONS: VE of one dose of Oka/Biken varicella vaccine was insufficient to control varicella. Therefore, two doses of Oka/Biken varicella vaccine is significant for controlling varicella in Japan.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Hattori F, Miura H, Sugata K, et al. Evaluating the effectiveness of the universal immunization program against varicella in Japanese children. Vaccine. 2017. PMID: 28784281. doi:10.1016/j.vaccine.2017.07.090

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。